Perrigo Company PLC hands the reins to its North America business to a former US Food and Drug Administration official soon after it made a priority of asking the agency to approve an oral contraceptive OTC switch.
Jim Dillard, chief scientific officer for the Dublin-based private label/store brand OTC giant since 2019, replaces Rich Sorota as president of the unit Perrigo calls Consumer Self-Care Americas, according to...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?